BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16152588)

  • 1. Effect of an anti-CD54 (ICAM-1) monoclonal antibody (UV3) on the growth of human uveal melanoma cells transplanted heterotopically and orthotopically in SCID mice.
    Wang S; Coleman EJ; Pop LM; Brooks KJ; Vitetta ES; Niederkorn JY
    Int J Cancer; 2006 Feb; 118(4):932-41. PubMed ID: 16152588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Fc portion of UV3, an anti-CD54 monoclonal antibody, is critical for its antitumor activity in SCID mice with human multiple myeloma or lymphoma cell lines.
    Coleman EJ; Brooks KJ; Smallshaw JE; Vitetta ES
    J Immunother; 2006; 29(5):489-98. PubMed ID: 16971805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antitumor activity of an anti-CD54 antibody in SCID mice xenografted with human breast, prostate, non-small cell lung, and pancreatic tumor cell lines.
    Brooks KJ; Coleman EJ; Vitetta ES
    Int J Cancer; 2008 Nov; 123(10):2438-45. PubMed ID: 18752248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-CD54 (ICAM-1) has antitumor activity in SCID mice with human myeloma cells.
    Huang YW; Richardson JA; Vitetta ES
    Cancer Res; 1995 Feb; 55(3):610-6. PubMed ID: 7834632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of anti-ganglioside antibodies on the metastatic spread of intraocular melanomas in a nude mouse model of human uveal melanoma.
    Niederkorn JY; Mellon J; Pidherney M; Mayhew E; Anand R
    Curr Eye Res; 1993 Apr; 12(4):347-58. PubMed ID: 8319494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of epidermal growth factor receptor in the metastasis of intraocular melanomas.
    Ma D; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1067-75. PubMed ID: 9620065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The generation and anti-myeloma activity of a chimeric anti-CD54 antibody, cUV3.
    Smallshaw JE; Coleman E; Spiridon C; Vitetta ES
    J Immunother; 2004; 27(6):419-24. PubMed ID: 15534485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and characterization of a panel of human uveal melanoma xenografts derived from primary and/or metastatic tumors.
    Némati F; Sastre-Garau X; Laurent C; Couturier J; Mariani P; Desjardins L; Piperno-Neumann S; Lantz O; Asselain B; Plancher C; Robert D; Péguillet I; Donnadieu MH; Dahmani A; Bessard MA; Gentien D; Reyes C; Saule S; Barillot E; Roman-Roman S; Decaudin D
    Clin Cancer Res; 2010 Apr; 16(8):2352-62. PubMed ID: 20371695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral picropodophyllin (PPP) is well tolerated in vivo and inhibits IGF-1R expression and growth of uveal melanoma.
    Economou MA; Andersson S; Vasilcanu D; All-Ericsson C; Menu E; Girnita A; Girnita L; Axelson M; Seregard S; Larsson O
    Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2337-42. PubMed ID: 18515579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between natural killer cell susceptibility and metastasis of human uveal melanoma cells in a murine model.
    Ma D; Luyten GP; Luider TM; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):435-41. PubMed ID: 7843912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of chemokine receptors on uveal melanoma cells and their metastases.
    Li H; Alizadeh H; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):636-43. PubMed ID: 18235009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral picropodophyllin (PPP) is well tolerated in vivo and inhibits IGF-1R expression and growth of uveal melanoma.
    Economou MA; Andersson S; Vasilcanu D; All-Ericsson C; Menu E; Girnita A; Girnita L; Axelson M; Seregard S; Larsson O
    Acta Ophthalmol; 2008 Nov; 86 Thesis 4():35-41. PubMed ID: 19032680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preliminary report on monoclonal antibodies against human uveal melanoma.
    Kalafut F; Kusenda J; Novotná L; Cernák A
    Neoplasma; 1987; 34(6):693-701. PubMed ID: 3431609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells.
    Girnita A; All-Ericsson C; Economou MA; Aström K; Axelson M; Seregard S; Larsson O; Girnita L
    Acta Ophthalmol; 2008 Nov; 86 Thesis 4():26-34. PubMed ID: 19032679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro targeting of NG2 antigen by 213Bi-9.2.27 alpha-immunoconjugate induces cytotoxicity in human uveal melanoma cells.
    Li Y; Wang J; Rizvi SM; Jager MJ; Conway RM; Billson FA; Allen BJ; Madigan MC
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4365-71. PubMed ID: 16303921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody.
    Guo Y; Ma J; Wang J; Che X; Narula J; Bigby M; Wu M; Sy MS
    Cancer Res; 1994 Mar; 54(6):1561-5. PubMed ID: 7511044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An orthotopic model for human uveal melanoma in SCID mice.
    Mueller AJ; Maniotis AJ; Freeman WR; Bartsch DU; Schaller UC; Bergeron-Lynn G; Cheng L; Taskintuna I; Chen X; Kan-Mitchell J; Folberg R
    Microvasc Res; 2002 Sep; 64(2):207-13. PubMed ID: 12204644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of human melanoma tumor growth in SCID mice by a human high molecular weight-melanoma associated antigen (HMW-MAA) specific monoclonal antibody.
    Hafner C; Breiteneder H; Ferrone S; Thallinger C; Wagner S; Schmidt WM; Jasinska J; Kundi M; Wolff K; Zielinski CC; Scheiner O; Wiedermann U; Pehamberger H
    Int J Cancer; 2005 Apr; 114(3):426-32. PubMed ID: 15578703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane-bound regulators of complement activation in uveal melanomas. CD46, CD55, and CD59 in uveal melanomas.
    Goslings WR; Blom DJ; de Waard-Siebinga I; van Beelen E; Claas FH; Jager MJ; Gorter A
    Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1884-91. PubMed ID: 8759358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells.
    Bosch JJ; Thompson JA; Srivastava MK; Iheagwara UK; Murray TG; Lotem M; Ksander BR; Ostrand-Rosenberg S
    Cancer Res; 2007 May; 67(9):4499-506. PubMed ID: 17483366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.